Andere talen Mithra Pharmaceuticals S.A.

Aandelen

Beurs gesloten - Euronext Bruxelles Andere beurzen 17:36:14 19-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,224 ^EUR	-3,86%		-0,88%	-82,14%

09/04	Mithra bereikt mijlpaal in onderzoek naar estetrol	AM
28/03	Noodlijdend Mithra stelt jaarverslag uit	AM

Early data from Mithra's ESTELLE pediatric study to be presented at two upcoming congresses	17/04
Mithra Pharmaceuticals S A : reaches milestone in estetrol skin study	08/04
Mithra reports full year 2023 financial results	08/03
Mithra Pharmaceuticals SA Reports Earnings Results for the Full Year Ended December 31, 2023	08/03
Mithra announces changes to its executive management	06/03
Mithra Pharmaceuticals to Initiate Monetization Process Involving Sale of Assets, Business	05/03
Mithra Pharmaceuticals Terminates CEO; Names CFO, COO as Successors	05/03
Mithra announces changes to its executive management	05/03
Mithra announces changes to its executive management	05/03
Mithra initiates monetization process, receives bridge loan from existing lenders	05/03
Mithra Pharmaceuticals SA Announces CEO Changes	05/03
Mithra - DONESTA safety study for menopause completes treatment phase and advances to data management and reporting phase	29/02
DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase	29/02
Mithra Pharmaceuticals Exits Stake in Mayne Pharma	16/02
Mithra sells shares in Mayne Pharma	15/02
An undisclosed buyer acquired a 5.06% stake in Mayne Pharma Group Limited from Mithra Pharmaceuticals SA for AUD 21 million	15/02
Mithra Announces its 2024 Financial Calendar	08/02
Mithra : le titre décroche, visibilité financière réduite	06/02
Mithra updates on cash position	06/02
Mithra updates on cash position	06/02

Geen resultaten voor deze zoekopdracht